BioSpace News Archive

Nanomedicine Market Size to Surpass US$ 866.26 Billion by 2029

According to Report, the global nanomedicine market size is expected to surpass around US$ 866.26 billion by 2029 from valued at US$ 377.37billion in 2021 and expanding growth at a CAGR of 11% from 2022 to 2030.

May 3, 2022
·
5 min read
Cryotherapy Market Size to Hit US$ 10.4 Billion in 2030

The global Cryotherapy market size is expected to hit around US$ 10.4 billion by 2030 and is projected to grow at a CAGR of 20.3% during forecast period 2021 to 2030.

May 3, 2022
·
6 min read
Biopharmaceutical CMO and CRO Market Size to Hit US$ 60.1 BN by 2030

The global biopharmaceutical CMO and CRO market was valued at USD 30.1 billion in 2020 and is expected to rake around USD 60.1 billion by 2030 with a CAGR of 7.6% during the forecast period 2022 to 2030.

May 3, 2022
·
4 min read
Caeregen Therapeutics Announces Data Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

Caeregen Therapeutics, LLC, a Michigan-based, regenerative medicine therapeutics company today announced data on Noregen™ from studies conducted with the Oakland University Eye Research Institute (ERI), at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting in Denver, CO.

May 3, 2022
·
4 min read
Gene Synthesis Market Size to Hit US$ 10.58 Billion by 2030

The global Gene Synthesis Market size is expected to hit around US$ 10.58 billion by 2030 and is anticipated to grow at a CAGR of 19.1% during forecast period 2021 to 2030.

May 3, 2022
·
5 min read
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2022

Freeline Therapeutics Holdings plc announced that on April 29, 2022, the Company granted five newly hired employees non-statutory options to purchase an aggregate of 57,850 of the Company’s ordinary shares.

May 3, 2022
·
1 min read
Biotech Beach

Eledon Pharmaceuticals to Participate in LifeSci Partners Immunology & Inflammation Symposium

Eledon Pharmaceuticals, Inc. announced that management will participate in a fireside chat at the LifeSci Partners Immunology & Inflammation Symposium on Tuesday, May 10th at 2:00 p.m. ET.

May 3, 2022
·
1 min read
Business

Y-mAbs to Announce First Quarter 2022 Financial and Operating Results on May 9, 2022

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter March 31, 2022 on Monday, May 9, 2022, after the close of the U.S. financial markets.

May 3, 2022
·
4 min read
Business

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2022 financial results on Thursday, May 12, 2022.

May 3, 2022
·
1 min read
Business

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, May 10, 2022.

May 3, 2022
·
1 min read